Page 7 - Nasdaq Amlx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq amlx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Amlx Today - Breaking & Trending Today

Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Down 6% Following Analyst Downgrade

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) shares traded down 6% on Tuesday after Mizuho lowered their price target on the stock from $52.00 to $50.00. The stock traded as low as $26.42 and last traded at $26.45. 626,594 shares traded hands during mid-day trading, a decline of 31% from the average session volume of […] ....

Justinb Klee , Georgem Milne Jr , Royal Bank , Life Insurance Co , Amylyx Pharmaceuticals Company Profile , Amylyx Pharmaceuticals Inc , News Ratings For Amylyx Pharmaceuticals Daily , Securities Exchange Commission , Wells Fargo Company , Amylyx Pharmaceuticals , Institutional Investors Weigh In On Amylyx Pharmaceuticals , China Universal Asset Management Co , Amylyx Pharmaceuticals Price Performance , Goldman Sachs Group , Insider Transactions At Amylyx Pharmaceuticals , Get Rating , Director George , Exchange Commission , Universal Asset Management , Amylyx Pharmaceuticals Daily , Nasdaq Amlx ,

Amylyx Pharmaceuticals (AMLX) Set to Announce Earnings on Thursday

Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) will be issuing its quarterly earnings data after the market closes on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.27) per share for the quarter. Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) last posted its quarterly earnings data on Monday, March 13th. The company reported ($0.65) […] ....

Gina Mazzariello , Amylyx Pharmaceuticals Trading , Amylyx Pharmaceuticals Inc , News Ratings For Amylyx Pharmaceuticals Daily , Securities Exchange Commission , Insider Activity At Amylyx Pharmaceuticals , Deutsche Bank , Pricet Rowe Associates Inc , Goldman Sachs Group , Institutional Trading Of Amylyx Pharmaceuticals , Metlife Investment Management , Amylyx Pharmaceuticals , Putnam Investments , Manufacturers Life Insurance Company , Get Rating , Morningside Venture Investment , Exchange Commission , Life Investment Management , Pricet Rowe Associates , Amylyx Pharmaceuticals Daily , Nasdaq Amlx ,

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives $50.50 Consensus Price Target from Analysts

Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) have been given an average recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price […] ....

United States , Patrickd Yeramian , Securities Exchange Commission , Vanguard Group Inc , Blackrock Inc , Amylyx Pharmaceuticals , Amylyx Pharmaceuticals Company Profile , Goldman Sachs Group , Hermes Inc , Analyst Recommendations For Amylyx Pharmaceuticals , News Ratings For Amylyx Pharmaceuticals Daily , Amylyx Pharmaceuticals Inc , Perceptive Advisors , Amylyx Pharmaceuticals Stock , Get Rating , Morningside Venture Investment , Exchange Commission , Federated Hermes , Amylyx Pharmaceuticals Daily , Nasdaq Amlx ,

Contrasting Amylyx Pharmaceuticals (AMLX) & Its Rivals

Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) is one of 994 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Amylyx Pharmaceuticals to related companies based on the strength of its institutional ownership, profitability, risk, valuation, analyst recommendations, earnings and dividends. Analyst Ratings This is a summary […] ....

United States , United Kingdom , Amylyx Pharmaceuticals Competitors , News Ratings For Amylyx Pharmaceuticals Daily , Amylyx Pharmaceuticals Inc , Amylyx Pharmaceuticals , Get Rating , Given Amylyx Pharmaceutical , Amylyx Pharmaceutical , Amylyx Pharmaceuticals Daily , Nasdaq Amlx , Stock Comparison , Stock Analysis ,

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Insider Sells $1,514,142.66 in Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) insider Patrick D. Yeramian sold 49,579 shares of the business’s stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $30.54, for a total value of $1,514,142.66. Following the completion of the sale, the insider now owns 208,417 shares […] ....

United States , Patrickd Yeramian , Amylyx Pharmaceuticals Company Profile , China Universal Asset Management Co , Amylyx Pharmaceuticals Stock Performance , Amylyx Pharmaceuticals Inc , Quarter For Amylyx Pharmaceuticals , Goldman Sachs Group , Life Insurance Co , Royal Bank , Loring Wolcott Coolidge Fiduciary Advisors , Amylyx Pharmaceuticals , Institutional Trading Of Amylyx Pharmaceuticals , News Ratings For Amylyx Pharmaceuticals Daily , High Net Worth Advisory Group , Get Rating , Universal Asset Management , Coolidge Fiduciary Advisors , Net Worth Advisory Group , Amylyx Pharmaceuticals Daily , Nasdaq Amlx , Insider Trading , Nsider Trades ,